9ZT0.MU - Alzamend Neuro Inc

Munich - Munich Delayed Price. Currency in EUR
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
4/30/2022
4/30/2021
4/30/2020
Total Revenue
0
0
0
0
Operating Expense
12,571
12,320
4,952
4,424
Operating Income
-12,571
-12,320
-4,952
-4,424
Net Non Operating Interest Income Expense
-22.021
-46.524
-157.097
13.925
Other Income Expense
-
4
62.418
-
Pretax Income
-12,589
-12,362
-5,047
-4,410
Net Income Common Stockholders
-12,589
-12,362
-5,047
-4,410
Diluted NI Available to Com Stockholders
-12,589
-12,362
-5,047
-4,410
Basic EPS
-
-0.14
-0.06
-0.05
Diluted EPS
-
-0.14
-0.06
-0.05
Basic Average Shares
-
89,095
84,930
89,763
Diluted Average Shares
-
89,095
84,930
89,763
Total Operating Income as Reported
-12,571
-12,320
-4,952
-4,424
Total Expenses
12,571
12,320
4,952
4,424
Net Income from Continuing & Discontinued Operation
-12,589
-12,362
-5,047
-4,410
Normalized Income
-12,593
-12,366
-5,109
-4,410
Interest Income
-
0
1.706
13.925
Interest Expense
22.021
46.524
158.803
-
Net Interest Income
-22.021
-46.524
-157.097
13.925
EBIT
-12,567
-12,316
-4,888
-4,424
EBITDA
-12,551
-
-
-
Reconciled Depreciation
15.969
3.549
-
-
Net Income from Continuing Operation Net Minority Interest
-12,589
-12,362
-5,047
-4,410
Total Unusual Items Excluding Goodwill
4
4
62.418
-
Total Unusual Items
4
4
62.418
-
Normalized EBITDA
-12,555
-12,316
-4,950
-4,424
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0

Yahoo Finance Plus Essential access required.

Learn more